Webinar
- April 17, 2026
Published: April 14, 2024
Author: Ernesto M.Nogueira
On April 10th we attended the thought-provoking event “Healthcare 2030: Envisioning the Next Decade,” hosted by IESE Business School in their beautiful Barcelona campus. The event brought together leading experts to delve into the imminent challenges, innovations, and unparalleled opportunities that will shape the future of healthcare.
As an AI-driven company passionate about revolutionizing healthcare, GenexAI found this event to be an invaluable source of insights into the evolving landscape of the industry, we were able to share ideas with the attendants on how to tackle the current challenges that different parties are facing.
In the next decade, the healthcare sector is poised to undergo a remarkable transformation driven by several converging factors. From an ageing population to groundbreaking advancements in life sciences, the potential of data-driven healthcare, and the emergence of generative AI; these dynamics will play a key role in the next years and demand innovative approaches and new business models to navigate effectively. More and better partnerships between technology providers and healthcare actors are expected to happen.
After attending the event we reinforced the idea that some of the most exciting prospects lie in the breakthroughs in biotechnology, genomics and pharmaceuticals. These advancements hold the promise of revolutionizing disease management and treatments. Technologies like CRISPR gene editing offer the potential not only to treat but also to cure genetic disorders, reshaping the future of healthcare delivery. Both patients and doctors shall be empowered in the near future thanks to innovations that are already taking place.
There was a consensus that generative AI emerges as a potent force in addressing paramount challenges within the sector. From improving healthcare delivery to enhancing how research is approached, AI has the potential to revolutionize various aspects of healthcare. With the exponential growth of health-related data fuelled by digitalization and wearable technologies, the opportunities for leveraging AI in healthcare are immense.
Macro dynamics like an increasing number of doctors that will retire and an ageing population that expects to live well past beyond 90 years were recurring topics during the event. Those topics convened with other factor like climate change (and its implications for new diseases) will shape the policies and focus of stakeholders in the sector.
GenexAI prioritizes the ethical and legal use of AI, ensuring that its solutions are always human validated to maintain trust and integrity. This was a point highlighted by various speakers at IESE, the importance of having a human validation when it comes to use generative AI in an industry like healthcare is a must and shall be pivotal for any stakeholder that is part of the ecosystem as well as using technology with ethics.
At the heart of this transformation lies the pursuit of a value-based healthcare approach. If we envision the healthcare landscape of 2030, it is crucial to prioritize ethical considerations, privacy protection, and the delicate balance between data revolution and patient confidentiality as well as taking into consideration that the definition of value changes depending on which actor you ask, as a healthcare professional will have different views from a patient or an insurance firm. What we all agree is that we shall move towards a model in which mundane tasks that can be automated are taken away from stakeholders like doctors or researchers in order to let them be more productive, happier and serve better their patients.
In a nutshell, the 30th IESE Healthcare event provided invaluable insights into the future of healthcare and the transformative role of technology. Looking ahead to 2030, collaboration, innovation, and ethical considerations will be paramount in shaping a healthier future for all. Platforms like GenexAI aim to be at the forefront of this transformation, empowering healthcare professionals to harness the potential of AI for the benefit of patients worldwide and contribute to a better future.
As we navigate this decade, GenexAI not only aims but is strategically positioned to be at the forefront of implementing AI-driven solutions that advocate for a healthier, more equitable future in healthcare in which all stakeholders are benefited. Our participation at the event underscores our role as a catalyst for change, heralding a new era of value-based, ethically grounded healthcare.
AI
Diagnostics
Events
Knowledge Base
Startup
AI
Events
Knowledge Base
Competitor Analysis
Knowledge Base
Market Segmentation
Systematic Literature Review
Diagnostics
Events
Competitor Analysis
Knowledge Base
Market Segmentation
Systematic Literature Review
Diagnostics
Competitor Analysis
Knowledge Base
Market Segmentation
Systematic Literature Review
Events
Competitor Analysis
Knowledge Base
Market Segmentation
Systematic Literature Review
Competitor Analysis
Competitor Analysis
Competitor Analysis
Competitor Analysis
Systematic Literature Review
Competitor Analysis
Knowledge Base
Market Segmentation
Competitor Analysis
Competitor Analysis
Competitor Analysis
Events
Competitor Analysis
Events
Systematic Literature Review
Competitor Analysis
Competitor Analysis
Knowledge Base
Market Segmentation
Systematic Literature Review
Competitor Analysis
Knowledge Base
Market Segmentation
Systematic Literature Review
Competitor Analysis
Competitor Analysis
Competitor Analysis
Knowledge Base
Market Segmentation
Systematic Literature Review
Competitor Analysis
Competitor Analysis
Competitor Analysis
Systematic Literature Review